Clinical evaluation of a novel fixed-dose combination tablet (Sentorpil® ForteGold) versus compounded powdered medications in dogs with myxomatous mitral valve disease: a randomized, double-blind study
The fixed-dose combination tablet (Sentorphil<sup>®</sup> ForteGold) offers a clinically effective and safer alternative to compounded powdered medications for managing MMVD in dogs. Its formulation ensures accurate dosing, improved owner compliance, and enhanced clinical outcomes. Further studies with larger populations and extended follow-up periods are warranted to confirm these findings.
Authors
- Changbaig Hyun (ORCID: https://orcid.org/0000-0001-6434-6930)
- Jiyoung Park (ORCID: https://orcid.org/0000-0002-0399-7083)
- Sang-Joon Lee (ORCID: https://orcid.org/0000-0001-6492-514X)
- Jiyoon Lee
Institutions
- The Schwarzman Animal Medical Center (US)
Publication Details
- Journal
- Frontiers in Veterinary Science
- Published
- 2025-08-12
- DOI
- https://doi.org/10.3389/fvets.2025.1622383
- Primary Topic
- Cardiovascular Conditions and Treatments
- Type
- article
- Field-Weighted Citation Impact
- 0.00